Key Takeaways
- • U.S. venture capital funding reached a record $276 billion across 9,700 deals in 2021, more than doubling 2020's $132 billion total and representing unprecedented capital deployment into technology and life sciences sectors.
- • Mega-deals ($100 million or larger) dominated deal activity, accounting for 59% of total funding volume with a 167% year-over-year increase, signaling a market shift toward larger, later-stage investments.
- • San Francisco Bay Area retained market leadership with 38% of total funding, while New York emerged as the fastest-growing major hub, increasing its allocation by 171% ($29 billion) year-over-year.
- • Technology sector captured 77% of all venture funding, with software, e-commerce, and cloud companies as primary beneficiaries; life sciences claimed 14% with Boston and the Bay Area dominating that subsector.
- • Secondary markets experienced explosive growth, with Philadelphia, Columbus, Raleigh-Durham, Dallas, and Phoenix each tripling funding levels in 2021, and Houston, Atlanta, and Raleigh-Durham leading life sciences funding expansion with multiples of 3x to 17x growth.
Summary
The U.S. venture capital market achieved historic proportions in 2021, with total funding reaching $276 billion across 9,700 deals—more than double the prior year's $132 billion, according to CBRE research. This record-setting capital deployment reflects sustained investor confidence in technology and life sciences innovation, with downstream effects on job creation and real estate demand across major innovation hubs.
Deal structure shifted markedly toward larger transactions. Mega-deals of $100 million or greater dominated the landscape, capturing 59% of funding volume and posting the highest growth rate at 167% year-over-year. Medium to large deals ($10 million to $100 million) accounted for 36% of volume with 63% growth, while smaller deals under $10 million represented just 5% of the total with 17% growth. This composition indicates investor preference for more mature, capital-intensive opportunities rather than early-stage ventures.
Geographic concentration remained pronounced but with notable deconcentration trends. San Francisco Bay Area continued its dominance with 38% of national funding, followed by New York (17%), Boston (11%), Los Angeles (6%), and San Diego (3%). However, New York demonstrated the strongest growth trajectory among top-five markets, expanding its venture allocation by 171% to reach $29 billion in new funding. Secondary markets showed exceptional dynamism, with Philadelphia, Columbus, Raleigh-Durham, Dallas, and Phoenix each recording funding volumes that more than tripled from 2020 levels.
Technology maintained its commanding market position, representing 77% of all venture capital investment in 2021, with software, e-commerce, and cloud computing attracting the largest allocations. Life sciences secured the second-largest share at 14%, with pronounced geographic concentration: Boston and San Francisco Bay Area captured the highest concentrations of life sciences funding. Growth in secondary markets was particularly pronounced in this sector, with Houston, Atlanta, and Raleigh-Durham posting year-over-year increases of 17x, 6x, and 3x respectively.
## DETAILED SUMMARY (continued)
The bifurcated market structure—combining historic peak capital availability with geographic diffusion—creates distinct implications for real estate demand, talent recruitment, and entrepreneurial ecosystem development across U.S. markets. Large venture rounds increasingly support expansion of existing high-growth companies and infrastructure buildout, while secondary market growth suggests emerging venture talent pools and cost-arbitrage dynamics are attracting both capital and entrepreneurs outside traditional Silicon Valley and coastal corridors.
Deal structure shifted markedly toward larger transactions. Mega-deals of $100 million or greater dominated the landscape, capturing 59% of funding volume and posting the highest growth rate at 167% year-over-year. Medium to large deals ($10 million to $100 million) accounted for 36% of volume with 63% growth, while smaller deals under $10 million represented just 5% of the total with 17% growth. This composition indicates investor preference for more mature, capital-intensive opportunities rather than early-stage ventures.
Geographic concentration remained pronounced but with notable deconcentration trends. San Francisco Bay Area continued its dominance with 38% of national funding, followed by New York (17%), Boston (11%), Los Angeles (6%), and San Diego (3%). However, New York demonstrated the strongest growth trajectory among top-five markets, expanding its venture allocation by 171% to reach $29 billion in new funding. Secondary markets showed exceptional dynamism, with Philadelphia, Columbus, Raleigh-Durham, Dallas, and Phoenix each recording funding volumes that more than tripled from 2020 levels.
Technology maintained its commanding market position, representing 77% of all venture capital investment in 2021, with software, e-commerce, and cloud computing attracting the largest allocations. Life sciences secured the second-largest share at 14%, with pronounced geographic concentration: Boston and San Francisco Bay Area captured the highest concentrations of life sciences funding. Growth in secondary markets was particularly pronounced in this sector, with Houston, Atlanta, and Raleigh-Durham posting year-over-year increases of 17x, 6x, and 3x respectively.
## DETAILED SUMMARY (continued)
The bifurcated market structure—combining historic peak capital availability with geographic diffusion—creates distinct implications for real estate demand, talent recruitment, and entrepreneurial ecosystem development across U.S. markets. Large venture rounds increasingly support expansion of existing high-growth companies and infrastructure buildout, while secondary market growth suggests emerging venture talent pools and cost-arbitrage dynamics are attracting both capital and entrepreneurs outside traditional Silicon Valley and coastal corridors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.